Sharemaestro company-news research for Doximity Inc (DOCS), showing current tone, evidence confidence, direct company coverage, sector and industry context, completed price response and the source headlines used on the page. Scores describe published news evidence. Confidence describes the amount, freshness, source breadth and direct company relevance of that evidence. Price context is shown separately.
Company news sentiment
DOCS news sentiment
Doximity Inc
Company headlines compared by relevance, subject, source independence, tone and the market's completed price response.
Current company news
News confirmed by price
Constructive news tone is drawn from 14 fresh independent stories, including 14 company-specific items across 3 publishers.
Latest source headline 1 Cash-Producing Stock with Promising Prospects and 2 We Ignore finance.yahoo.com · 12 Aug 2026 04:37What supports the read
14 current stories are mapped specifically to DOCS.
The read spans 3 publishers rather than depending on one outlet.
Cross-story agreement is 81/100, indicating a comparatively coherent tape.
Constructive news tone is being confirmed by positive weekly price action.
What tempers the read
No material evidence constraint is currently dominant.
News history
Tone and story flow over 21 days
Evidence confidence
What supports the score
Confidence rises through sample depth, independent publishers, direct company relevance, freshness and agreement. A high or low tone score is not itself evidence of reliability.
Price context
Sentiment against the 26-week price path
Constructive news tone is being confirmed by positive weekly price action.
News subjects
What is shaping the score
Source mix
Where the evidence comes from
Recurring subjects
Subjects appearing most often
Earlier readings
How the score has changed
Source headlines
The news behind the score
Every row shows the public evidence used to understand the read. Direct company stories carry more weight than industry or sector context; duplicate coverage is consolidated before scoring.
1 Cash-Producing Stock with Promising Prospects and 2 We Ignore
1 Cash-Producing Stock with Promising Prospects and 2 We Ignore Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities. Not all companies are created equal, and StockStory is here to surface the ones with real upside. That said, here is one cash-producing company that reinvests wisely to drive long-term success and two that may face some trouble. Two Stocks to Sell: Doximity (DOCS) Trailing 12-Month Free Cash Flow Margin: 45.3% With over 80% of U.S. ph
- Published
- 12 Aug 2026 04:37
- Catalyst
- Earnings
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
Atlassian and Doximity Just Surged 30% After Earnings: 3 Software Stocks with the Same Setup
It's a great feeling when a stock you own absolutely skyrockets higher after reporting earnings. Two software-as-a-service (SaaS) stocks, Atlassian (NASDAQ: TEAM) and Doximity (NYSE: DOCS), gave their investors something to cheer about when both companies' share prices skyrocketed more than 30% this past Friday, Aug. 7, following their earnings reports. The two stocks had a few things in common going into the report. They both operate vertical-focused software platforms. In the case of Atlassian, its focus is on enterprise workflows, while Doximity's platform is centered on clinical workflows
- Published
- 11 Aug 2026 17:49
- Catalyst
- Earnings
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
DOCS Q2 Deep Dive: AI Product Adoption Fuels Revenue Growth, Margins Face Investment Pressures
DOCS Q2 Deep Dive: AI Product Adoption Fuels Revenue Growth, Margins Face Investment Pressures Medical professional network Doximity (NYSE:DOCS) reported revenue ahead of Wall Street's expectations in Q2 CY2026, with sales up 7.3% year on year to $156.6 million. The company expects next quarter's revenue to be around $170.5 million, close to analysts' estimates. Its non-GAAP profit of $0.29 per share was 4.2% below analysts' consensus estimates. Is now the time to buy DOCS? Find out in our full research report (it's free). Doximity (DOCS) Q2 CY2026 Highlights: Revenue: $156.6 million vs analys
- Published
- 11 Aug 2026 08:21
- Catalyst
- Earnings
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
Stocks making the biggest moves midday: NetApp, Intel, Apple, Doximity, Verisk Analytics & more
Check out some of the companies making the biggest moves midday: MarineMax — The boat and yacht retailer soared 46% after agreeing to be sold to Blackstone Infrastructure's Safe Harbor Marinas for $53 a share in cash, or $1.5 billion. The deal's expected to close by the end of 2026. Varex Imaging — The imaging component maker climbed 48% after Teledyne Technologies agreed to buy Varex for $18.90 a share in cash. The deal is expected to close in early 2027. Teledyne rose a fraction. Artificial intelligence infrastructure — Stocks tied to artificial intelligence infrastructure slid. The Global X
- Published
- 10 Aug 2026 17:43
- Catalyst
- Deals and strategy
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
Apple downgraded, HPE upgraded: Wall Street's top analyst calls
Apple downgraded, HPE upgraded: Wall Street's top analyst calls The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top Upgrades: Morgan Stanley upgraded HPE (HPE) to Overweight from Equal Weight with a price target of $69, down from $71. The firm admits to having been on the wrong side of the enterprise hardware trade, previously believing that record component inflation would quickly stymie a recovery in hardware spending, but its AlphaWise survey confirms this cyc
- Published
- 10 Aug 2026 13:39
- Catalyst
- Analyst action
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
Doximity Draws Its First Downgrade Days After Its Pop
This article first appeared on GuruFocus. Doximity (NYSE:DOCS), a digital platform for U.S. medical professionals, was up 0.51% premarket despite a Wells Fargo downgrade to Underweight from Equal Weight and an $18 price target. The call lands days after the stock jumped 32.58% on its earnings report. Analyst Stan Berenshteyn said Doximity's outlook is essentially unchanged, but the stock now trades close to faster-growing peers after the run-up. At the current $27, it trades at about 32x earnings despite revenue growth of roughly 11% over the past year. He argued the remaining upside leans on
- Published
- 10 Aug 2026 12:20
- Catalyst
- Analyst action
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
Doximity (DOCS) Stock Fair Value Rises After Split Analyst Views On AI Growth
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Doximity's updated fair value estimate has moved from US$24.37 to US$28.00, which represents roughly a 15% uplift in the latest model. This shift lines up with the split analyst narrative, where some firms point to improving execution and AI traction, while others focus on execution risk, competition in healthcare AI, and the path for longer term growth. As you read on, you will see how to track these changing views and what to watch as the story around Doximity continues to
- Published
- 09 Aug 2026 09:10
- Catalyst
- Analyst action
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
Doximity (DOCS) Is Up 31.0% After Raising Revenue Outlook On Clinical AI Adoption - Has The Bull Case Changed?
Doximity, Inc. recently reported fiscal first-quarter 2027 results, with revenue rising to US$156.62 million from US$145.91 million a year earlier, while net income and earnings per share declined year on year. Management emphasized rapid uptake and monetization of its clinical AI tools, updating guidance to US$170–171 million for second-quarter revenue and US$671–681 million for full-year revenue. We'll now examine how Doximity's raised revenue outlook, underpinned by accelerating adoption of its AI-powered products, shapes its broader investment narrative. The best AI stocks today may lie be
- Published
- 08 Aug 2026 21:15
- Catalyst
- Earnings
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
Why Doximity Stock Skyrocketed on Friday
Shares of Doximity (NYSE: DOCS) surged on Friday after management highlighted the remarkable returns it was beginning to realize on its artificial intelligence (AI) investments.Image source: Getty Images. Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue » Q1 results were just part of the story Doximity's revenue rose 7% year over year to $156.6 million in its fiscal 2027 firs
- Published
- 08 Aug 2026 17:26
- Catalyst
- Earnings
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
Doximity Q1 Earnings Call Highlights
Key Points Interested in Doximity, Inc.? Here are five stocks we like better. Strong Q1 performance: Doximity's fiscal 2027 first-quarter revenue rose 7% year over year to $157 million, while adjusted EBITDA reached $75 million, a 48% margin. The company raised its full-year revenue outlook to $671 million–$681 million. Clinical AI adoption accelerated: Workflow prescribers using Doximity's AI tools nearly doubled as a share of active users, AI prompt volume increased more than 25% sequentially, and AI Scribe usage rose tenfold year over year. Doximity said its Ask product had the lowest error
- Published
- 08 Aug 2026 05:03
- Catalyst
- Earnings
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
Stocks Settle Higher as a Weak Jobs Report Allays Rate Hike Fears
The S&P 500 Index ($SPX) (SPY) closed up +0.62% on Friday, the Dow Jones Industrial Average ($DOWI) (DIA) closed up +0.28%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed up +1.19%. September E-mini S&P futures (ESU26) rose +0.55%, and September E-mini Nasdaq futures (NQU26) rose +1.17%. Stock indices settled higher on Friday amid strength in corporate earnings results and reduced Fed rate hike fears. Stock indices found support on Friday as bond yields fell after US July nonfarm payrolls unexpectedly declined and average hourly earnings rose less than expected, bolstering speculation that the
- Published
- 07 Aug 2026 22:18
- Catalyst
- Earnings
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
Why Doximity Stock Is Soaring 38% After an Earnings Miss
Shares surge, even after the medical networking and telehealth company’s earnings miss analysts’ targets. Continue Reading
- Published
- 07 Aug 2026 19:18
- Catalyst
- Earnings
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
Why Doximity Stock Is Up 80%
This article first appeared on GuruFocus. Doximity (NYSE:DOCS), a digital platform for U.S. medical professionals, rose 79.82% intraday, after comments about the margins on its new AI search tool. CEO Jeffrey Tangney told analysts the product earns more than 10 times per search in revenue than it costs to run. The quarter itself was solid but not enough to explain the move. Revenue rose 7% to $156.6 million and adjusted EBITDA was $74.8 million, both above consensus, and Doximity raised its full-year revenue guidance by $6 million to a range of $671 million to $681 million. Piper Sandler's Jes
- Published
- 07 Aug 2026 18:43
- Catalyst
- Earnings
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
SpaceX, Doximity, Trade Desk, Rigetti, Coherent, and More Stocks That Explain Today’s Market
FEATURE Stocks rose Friday with tech names picking up steam after the U.S. jobs report for July was softer than expected, resulting in Wall Street rethinking whether the Federal Reserve will raise interest rates any time soon. Continue Reading
- Published
- 07 Aug 2026 18:03
- Catalyst
- Macro sensitivity
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
Earlier company news
DOCS news archive
Stored newest first for historical research. These older headlines are retained for reference and do not contribute to the current sentiment gauge above.
The archive is starting now
Each successful collection will retain its qualifying headlines here instead of replacing the previous set.
How the page works
How to read the score
It describes the weighted balance of qualifying headlines. A score of 50 can mean a balanced tape or that direction has been withheld for insufficient evidence; the status label distinguishes them.
Confidence measures depth, source breadth, direct relevance, freshness and agreement. It does not rise merely because the tone is extreme.
Weekly price response, trend and fair-value position test whether the market is accepting or rejecting the news. They never rewrite the news score.
The page describes completed evidence available at the stated time. It is research context, not a forecast, recommendation, target or execution instruction.